About Restylane® Shaype™
Restylane® Shaype™ is a hyaluronic acid (HA) injectable with the firmest formula. It is specifically designed to sculpt the lower face. The filler is injected deep into the bone and mimics its structure. The results are immediate and last longer than other dermal fillers for the chin. Most aestheticians opt for this filler to give their clients a softer and balanced look. Moreover, once the filler adjusts to the bone, it provides the jawline with a slimmer and stronger appearance. Since the HA gel is minimally modified, it resembles the structure of the HA already present in the skin. Hence, the results of Restylane® Shaype™ can be reversed.
Key Features
- NASHA HD™ Technology: Enhances HA’s crosslinking efficiency, giving the gel stability and strength.
- High G-Prime (G’): Allows the gel to maintain its shape. This helps provide excellent support and lift.
- Deep Injection Technique: Enables a well-defined and structured chin.
- Shayping Technique™: Helps balance facial features by highlighting the contours.
How Does It Work?
Restylane® Shaype™ is injected into the supraperiosteal layer (deep into the bone) to enhance chin shape and projection. The high-density, firm HA supports the soft tissue and overlying skin, creating a more sculpted and structured appearance.
- It balances facial proportions by enhancing chin projection.
- It reduces the appearance of a weak chin, strengthens the jawline, and improves facial definition.
- It doesn’t involve any stiffness that usually occurs after surgical implants, providing the chin with natural movement.
Results
Restylane® Shaype™ provides long-lasting results. They are visible immediately after the injection due to the volumizing effect of the HA gel. The duration is between 12 and 18 months, depending on factors like metabolism, injection site, and technique.
Composition
- Sodium hyaluronate gel 25 mg/mL
- Lidocaine hydrochloride 3 mg/mL
- Phosphate-buffered saline, pH 7 q.s. ad 1 mL 1
Produced from pharmaceutical-grade sodium hyaluronate and crosslinking agent BDDE.